Humacyte, Inc. (HUMA)

Last Closing Price: 0.71 (2026-04-17)

EBITDA Margin (Quarterly)

EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues

Humacyte, Inc. (HUMA) EBITDA Margin data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
$0.47M
$-24.80M
$9.08M
$-8.62M
$31.30M
$-30.84M
$6.03M
$-24.80M
$-24.80M
$-24.80M
$-24.80M
$-24.80M
$-24.80M
$-30.84M
$-29.05M
158.16M
158.16M
$-0.19
$-0.19
Balance Sheet Financials
$67.80M
$18.54M
$48.57M
$116.37M
$18.37M
$62.42M
$94.89M
$113.26M
$3.11M
$3.11M
$3.11M
193.00M
Cash Flow Statement Financials
$-105.04M
$-0.88M
$61.49M
$95.29M
$50.85M
$-44.44M
$9.75M
--
--
Fundamental Metrics & Ratios
3.69
--
--
0.95
20.86
-1844.75%
-6603.00%
-6603.00%
EBITDA Margin
--
-5311.35%
-5311.35%
$-105.93M
--
--
--
0.00
0.67
1.06
84.99
-797.81%
-797.81%
-21.32%
-37.85%
$0.02
$-0.67
$-0.66